[
    [
        {
            "time": "",
            "original_text": "上海医药子公司产“龙虎人丹”不合格被通报 因重量存差异 产品问题",
            "features": {
                "keywords": [
                    "上海医药",
                    "龙虎人丹",
                    "不合格",
                    "通报",
                    "重量差异",
                    "产品问题"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海医药子公司产“龙虎人丹”不合格被通报 因重量存差异 产品问题",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "上海医药(02607.HK)完成发行2020年度第四期超短期融资券",
            "features": {
                "keywords": [
                    "上海医药",
                    "融资券",
                    "发行",
                    "2020年度",
                    "第四期",
                    "超短期"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药(02607.HK)完成发行2020年度第四期超短期融资券",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "上海医药(601607.SH)完成发行2020年度第四期超短期融资券",
            "features": {
                "keywords": [
                    "上海医药",
                    "融资券",
                    "发行",
                    "2020年度",
                    "第四期",
                    "超短期"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药(601607.SH)完成发行2020年度第四期超短期融资券",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "智通AH统计|10月21日",
            "features": {
                "keywords": [
                    "智通",
                    "AH统计",
                    "10月21日"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智通AH统计|10月21日",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "上市药企资本变局不断：丽珠分拆上市 CRO将现第四家A+H企业",
            "features": {
                "keywords": [
                    "上市药企",
                    "资本变局",
                    "丽珠",
                    "分拆上市",
                    "CRO",
                    "A+H企业"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上市药企资本变局不断：丽珠分拆上市 CRO将现第四家A+H企业",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]